Table 4.
Pearson's correlation of serum and salivary Dsgs values in all 86 PV patients and 62 PV patients with mucocutaneous phenotype.
| Values* | Correlation coefficient (r) | P | ||
|---|---|---|---|---|
| In all patients (N = 86) | Serum anti-Dsg-1 | Serum anti-Dsg-3 | 0.332 | 0.002 |
| Saliva anti-Dsg-1 | Saliva anti-Dsg-3 | 0.629 | <0.001 | |
| Serum anti-Dsg-1 | Saliva anti-Dsg-1 | 0.337 | 0.001 | |
| Serum anti-Dsg-3 | Saliva anti-Dsg-3 | 0.435 | <0.001 | |
|
| ||||
| In patients with mucocutaneous phenotype (N = 62) | Serum anti-Dsg-1 | Serum anti-Dsg-3 | 0.271 | 0.033 |
| Saliva anti-Dsg-1 | Saliva anti Dsg-3 | 0.659 | <0.001 | |
| Serum anti-Dsg-1 | Saliva anti Dsg-1 | 0.319 | 0.012 | |
| Serum anti-Dsg-3 | Saliva anti Dsg-3 | 0.353 | 0.005 | |
*Values (RU/mL) have been provided in Table 2.